{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The first drug to treat fibromyalgia has been approved, but some dispute the very existence of the condition. ", "headline": {"main": "Drug Approved. Is Disease Real?", "sub": "Some Doctors Dispute Existence of a Pain  ;", "print_headline": "Drug Approved. Is Disease Real?"}, "abstract": null, "print_page": "1", "word_count": "1708", "_id": "547cca33798810275e3838c0", "snippet": "The first drug to treat fibromyalgia has been approved, but some dispute the very existence of the condition.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/14/health/14pain.html", "multimedia": [{"subtype": "wide", "url": "images/2008/01/14/us/fibro_190.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/01/14/us/fibro_190.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Fibromyalgia", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Pain", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Alex", "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2008-01-14T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors. For patient advocacy groups and doctors who specialize in fibromyalgia, the Lyrica approval is a milestone. They say they hope Lyrica and two other drugs that may be approved this year will legitimize fibromyalgia, just as Prozac brought depression into the mainstream.", "headline": {"main": "Drug Approved. Is Disease Real?"}, "abstract": "Food and Drug Administration's approval of Lyrica, developed by Pfizer to treat fibromyalgia, may help legitimize controversial condition, diagnosis that some doctors reject; fibromyalgia affects primarily middle-aged women and is characterized by chronic, widespread pain of unknown origin; its sufferers do not typically respond to conventional painkillers, so drug companies are focusing on medicines that affect brain and perception of pain; advocacy groups and doctors who treat fibromyalgia estimate 2 percent to 4 percent are afflicted, but figures are disputed by doctors who do not consider it recognized illness and who say that diagnosing condition worsens suffering by causing patients to obsess over aches that other people tolerate; they warn that Lyrica's side effects, which include severe weight gain, dizziness and edema, are real and dangerous; despite debate, American College of Rheumatology, FDA and insurers do recognize it as diagnosable disease; Eli Lilly and Forest Laboratories have asked FDA for permission to market drugs and approval appears likely by end of year; graph; photos (M)", "print_page": "1", "word_count": 1707, "_id": "4fd294c18eb7c8105d86fa03", "snippet": "Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors.     For patient advocacy groups and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F0DEEDA103FF937A25752C0A96E9C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOREST LABORATORIES"}, {"name": "organizations", "value": "AMERICAN COLLEGE OF RHEUMATOLOGY"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "AGE, CHRONOLOGICAL"}, {"name": "subject", "value": "DIZZINESS"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "FIBROMYALGIA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "LYRICA (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Alex", "rank": 1, "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2008-01-14T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Researchers at Harvard Medical School have identified 273 proteins that the AIDS virus needs to survive in human cells, which could lead to new strategies for combating the disease.", "headline": {"main": "Study Finds Possible Targets for H.I.V. Drugs", "print_headline": "H.I.V. Research Opens Up Potential Targets for Drugs"}, "abstract": null, "print_page": "11", "word_count": "710", "_id": "547cacdc798810275e3835f4", "snippet": "Researchers at Harvard Medical School have identified 273 proteins that the AIDS virus needs to survive in human cells, which could lead to new strategies for combating the disease.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/11/science/11hiv.html", "multimedia": [{"subtype": "wide", "url": "images/2008/01/11/science/hivgraph190.gif", "height": 126, "width": 190, "legacy": {"wide": "images/2008/01/11/science/hivgraph190.gif", "wideheight": "126", "widewidth": "190"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Proteins", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Harvard Medical School", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Elledge, Stephen J", "is_major": "N", "rank": "6", "name": "persons"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2008-01-11T00:00:00Z", "section_name": "Science"}, {"type_of_material": "News", "blog": [], "news_desk": "ContinuousNews", "lead_paragraph": "Researchers at Harvard Medical School have identified 273 proteins that the AIDS virus needs to survive in human cells, opening up new potential targets for drugs.", "headline": {"main": "Study Finds Possible Targets for AIDS Drugs ", "print_headline": "Harvard Study Finds Potential Targets for AIDS Drugs"}, "abstract": null, "print_page": null, "word_count": "676", "_id": "547cab12798810275e3835c7", "snippet": "Researchers at Harvard Medical School have identified 273 proteins that the AIDS virus needs to survive in human cells, opening up new potential targets for drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/10/health/10cnd-aids.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2008-01-10T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Despite the well-established danger from urinary catheters, a new study finds that hospitals are doing very little to reduce the risks of infection. ", "headline": {"main": "Risks: Lax Catheter Policies Seen at Many Hospitals", "kicker": "Vital Signs", "print_headline": "Lax Catheter Policies Seen at Many Hospitals", "content_kicker": "Vital Signs"}, "abstract": null, "print_page": "6", "word_count": "275", "_id": "547c8ad9798810629fb0d6a2", "snippet": "Despite the well-established danger from urinary catheters, a new study finds that hospitals are doing very little to reduce the risks of infection.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/08/health/research/08risk.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2008/01/08/health/08risk.751.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/08/health/08risk.751.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Research", "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Hospitals", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Urinary Tract", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Bladder", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Bacteria", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Eric", "lastname": "NAGOURNEY"}], "original": "By ERIC NAGOURNEY"}, "document_type": "article", "pub_date": "2008-01-08T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The search for new treatments can be tricky when the disease is fearsome but nearly forgotten because its victims are poor and obscure.", "headline": {"seo": "African Sleeping Sickness - Medicine and Health - Bill and Melinda Gates Foundation - Research", "main": "Jump-Start on Slow Trek to Treatment for a Disease", "print_headline": "Jump-Start On Slow Trek To Treatment For a Disease"}, "abstract": null, "print_page": "5", "word_count": "999", "_id": "547c77b2798810629fb0d4d0", "snippet": "The search for new treatments can be tricky when the disease is fearsome but nearly forgotten because its victims are poor and obscure.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/08/health/research/08slee.html", "multimedia": [{"subtype": "xlarge", "url": "images/2008/01/08/health/08observe.xlarge1.jpg", "height": 350, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2008/01/08/health/08observe.xlarge1.jpg", "xlargeheight": "350"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/01/08/health/08observe.751.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/08/health/08observe.751.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Research", "keywords": [{"value": "Sleeping Sickness", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Parasites", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Gates, Bill and Melinda, Foundation", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "World Health Organization", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2008-01-08T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Trying to avoid vertigo, falls and other hazards of lost equilibrium. ", "headline": {"kicker": "Personal Health", "main": "Preserving a Fundamental Sense: Balance", "sub": "Testing for Equilibrium ;", "print_headline": "Preserving a Fundamental Sense: Balance", "content_kicker": "Personal Health"}, "abstract": null, "print_page": "7", "word_count": "1139", "_id": "547c7688798810629fb0d4b6", "snippet": "Trying to avoid vertigo, falls and other hazards of lost equilibrium.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/01/08/health/08brod.html", "multimedia": [{"subtype": "wide", "url": "images/2008/01/07/health/0108-sci-BRODY190.126.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/01/07/health/0108-sci-BRODY190.126.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/01/08/health/08brody.751.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/01/08/health/08brody.751.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Vertigo", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Aged", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2008-01-08T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Notable research studies now enrolling patients.", "headline": {"main": "Selected Studies: Exercise", "kicker": "Clinical Trials", "print_headline": "Selected Studies: Exercise", "content_kicker": "Clinical Trials"}, "abstract": null, "print_page": null, "word_count": "434", "_id": "5342e11e7988106f3076e513", "snippet": "Notable research studies now enrolling patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/ref/health/healthguide/esn-exercise-trials.html", "multimedia": [], "subsection_name": "Health Guide", "keywords": [{"value": "Breast", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Exercise", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Women", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Diabetes", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Obesity", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "4", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2008-01-08T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 8, "offset": 0, "time": 24}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}